Goldman Sachs
PROK icon

Goldman Sachs’s ProKidney PROK Stock Holding History

Goldman Sachs’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$755K Sell
421,902
-259,259
-38% -$550K ﹤0.01% 5297
2025
Q4 		$1.53M Buy
681,161
+516,544
+314% +$1.36M ﹤0.01% 4814
2025
Q3 		$398K Sell
164,617
-416,206
-72% -$1.11M ﹤0.01% 5626
2025
Q2 		$344K Buy
580,823
+362,854
+166% +$283K ﹤0.01% 5369
2025
Q1 		$191K Sell
217,969
-74,027
-25% -$103K ﹤0.01% 5653
2024
Q4 		$493K Buy
291,996
+103,907
+55% +$187K ﹤0.01% 5255
2024
Q3 		$361K Buy
188,089
+143,072
+318% +$325K ﹤0.01% 5218
2024
Q2 		$111K Sell
45,017
-4,247
-9% -$11.4K ﹤0.01% 5390
2024
Q1 		$80.8K Buy
49,264
+11,631
+31% +$17.1K ﹤0.01% 5273
2023
Q4 		$67K Sell
37,633
-12,602
-25% -$27K ﹤0.01% 5349
2023
Q3 		$230K Sell
50,235
-35,721
-42% -$342K ﹤0.01% 4990
2023
Q2 		$962K Buy
85,956
+67,314
+361% +$716K ﹤0.01% 4361
2023
Q1 		$211K Buy
18,642
+2,920
+19% +$31.1K ﹤0.01% 5278
2022
Q4 		$108K Buy
+15,722
New +$150K ﹤0.01% 5463
2022
Q3 		– Sell
-43,400
Closed -$432K – 6473
2022
Q2 		$432K Buy
+43,400
New +$429K ﹤0.01% 5182

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs's PROK Position: Q1 2026 in Review

Goldman Sachs reduced its ProKidney (PROK) stake by 38% in Q1 2026, selling an estimated $550K and leaving 421,902 shares worth $755K. The position accounts for ﹤0.01% of the portfolio, ranked #5297.

Goldman Sachs first reported a position in PROK in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.53M in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Goldman Sachs held 421,902 shares of ProKidney worth $755K as of Q1 2026.
  • Goldman Sachs sold 259,259 ProKidney shares in Q1 2026, an estimated $550K.
  • ProKidney made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5297 holding.
  • Goldman Sachs first reported a position in ProKidney in Q2 2022 and has held it in 15 quarters since.
  • Goldman Sachs's ProKidney position peaked at $1.53M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.